Las Vegas, NV -- (SBWIRE) -- 02/04/2013 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume leaders as reported by http://beststocksdaily.com/
Gilead Sciences, Inc. (NASDAQ:GILD) added 0.35% and is trading at $40.70. Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Gilead’s primary areas of focus include human immunodeficiency virus (HIV)/AIDS, liver diseases, such as hepatitis B and C and cardiovascular/metabolic and respiratory conditions.
Can GILD Continues To Move Higher Back? Find Out Here http://beststocksdaily.com/p2/index.php?company=GILD
Celsion Corporation (NASDAQ:CLSN) is lower 10.61% and is trading at $1.18. Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis (CRLM) and a Phase II clinical trial for recurrent chest wall breast cancer.
Get Free Trend Analysis on CLSN Here http://beststocksdaily.com/p2/index.php?company=CLSN
Peregrine Pharmaceuticals (NASDAQ:PPHM) added 2.36% and is trading at $2.17. Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies.
To Get complete technical analysis on PPHM go to http://beststocksdaily.com/p2/index.php?company=PPHM
Inovio Pharmaceuticals, Inc. (NYSE:INO) is higher 2.35% and is trading at $0.727. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV).
Get Free Trend Analysis on INO Here http://beststocksdaily.com/p2/index.php?company=INO
Cell Therapeutics Inc (NASDAQ:CTIC) is lower 4.17% and is trading at $1.38. Cell Therapeutics, Inc. (CTI) develops, acquires and commercializes treatments for cancer. The Company’s research, development, acquisition and in-licensing activities concentrate on identifying and developing new ways to treat cancer.
To Get complete technical analysis on CTIC go to http://beststocksdaily.com/p2/index.php?company=CTIC
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)